• $1.1M
    Market Cap
  • 35.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
588,957
-83.96%
3.7M
N/A
Cost of Revenue
1.1M
-67.01%
3.4M
N/A
Gross Profit
-530,168
-289.03%
280,465
N/A
Sales and Marketing Expense
7,660
-95.48%
169,350
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
93,223
+12.47%
82,889
N/A
Total Operating Expenses
1.9M
+26.82%
1.5M
N/A
Operating Profit
-2.4M
+100.26%
-1.2M
N/A
Interest Income
N/A
N/A
-169,832
N/A
Interest Expense
-1.7M
-19.66%
-2.1M
N/A
Interest Income and Expense and Net
-1.7M
-25.68%
-2.3M
N/A
Total Nonoperating Income and Expense
-3.1M
+8.37%
-2.9M
N/A
Income before Taxes
-5.5M
+35.69%
-4.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
195,385
N/A
Net Income
-5.5M
+35.68%
-4.1M
N/A
Net Income from Continuing Operations Applicable to Common
-5.5M
+35.69%
-4.1M
N/A
Basic EPS and Net Income
-0.01
0.00%
-0.01
N/A
Diluted EPS and Net Income
-0.01
0.00%
-0.01
N/A
Basic Weighted Average Shares
515.3M
+3.43%
498.2M
N/A
Diluted Weighted Average Shares
515.3M
+3.43%
498.2M
N/A
Balance Sheet
Cash and Cash Equivalents
9,095
-96.97%
299,895
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
9,095
-96.97%
299,895
N/A
Total Current Assets
714,199
-24.73%
948,862
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
1.8M
-1.19%
1.8M
N/A
Total Long-Term Assets
7,459
0.00%
7,459
N/A
Total Assets
2.8M
-7.64%
3.0M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
4.6M
+192.67%
1.6M
N/A
Total Current Liabilities
7.7M
+75.90%
4.4M
N/A
Total Long-Term Debt
908,617
-71.86%
3.2M
N/A
Total Long-Term Liabilities
927,383
-72.31%
3.3M
N/A
Total Liabilities
8.6M
+11.67%
7.7M
N/A
Retained Earnings
-16.8M
+48.62%
-11.3M
N/A
Total Stockholders Equity
-5.8M
+24.11%
-4.7M
N/A
Total Shares Outstanding
557.2M
+10.18%
505.7M
N/A
Cash Flow
Cash from Operating Activities
-1.2M
-25.99%
-1.6M
N/A
Capital Expenditures
62,319
+101.51%
30,926
N/A
Cash from Investing Activities
-62,250
+101.29%
-30,926
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
974,838
-42.32%
1.7M
N/A
Financials Ratio
Gross Margin
-90.02%
-1,278.68%
7.64%
N/A
Operating Margin
-410.14%
+1,148.68%
-32.85%
N/A
Return on Assets
-187.71%
+33.97%
-140.11%
N/A
Return on Equity
104.97%
+17.91%
89.03%
N/A
Revenue Growth
-83.96%
-111.76%
713.92%
N/A
Current Ratio
0.09
-57.22%
0.22
N/A
Cash Ratio
0.001
-98.25%
0.07
N/A
Debt-to-Equity Ratio
-0.95
-7.46%
-1.03
N/A
Debt-to-Assets Ratio
1.96
+24.33%
1.58
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow